The US AI Safety Institute stands on shaky ground

Date:

Share post:


One of the only U.S. government offices dedicated to assessing AI safety is in danger of being dismantled if Congress doesn’t choose to authorize it.

The U.S. AI Safety Institute (AISI), a federal government body that studies risks in AI systems, was created in November 2023 as a part of President Joe Biden’s AI Executive Order. The AISI operates within NIST, an agency of the Commerce Department that develops guidance for the deployment of various categories of technologies.

But while the AISI has a budget, a director, and a research partnership with its counterpart in the U.K., the U.K. AI Safety Institute, it could be wound down with a simple repeal of Biden’s executive order.

“If another president were to come into office and repeal the AI Executive Order, they would dismantle the AISI,” Chris MacKenzie, senior director of communications at Americans for Responsible Innovation, an AI lobby group, told TechCrunch. “And [Donald] Trump has promised to repeal the AI Executive Order. So Congress formally authorizing the AI Safety Institute would ensure its continued existence regardless of who’s in the White House.”

Beyond assuring the AISI’s future, authorizing the office could also lead to more stable, long-term funding for its initiative from Congress. The AISI currently has a budget of around $10 million — a relatively small amount considering the concentration of major AI labs in Silicon Valley.

“Appropriators in Congress tend to give higher budgeting priority to entities formally authorized by Congress,” MacKenzie said, “with the understanding that those entities have broad buy-in and are here for the long run, rather than just a single administration’s one-off priority.”

In a letter today, a coalition of over 60 companies, nonprofits, and universities called on Congress to enact legislation codifying the AISI before the end of the year. Among the undersigners are OpenAI and Anthropic, both of which have signed agreements with the AISI to collaborate on AI research, testing, and evaluation.

The Senate and House have each advanced bipartisan bills to authorize the activities of the AISI. But the proposals have faced some opposition from conservative lawmakers, including Sen. Ted Cruz (R-Texas), who’s called for the Senate version of the AISI bill to pull back on diversity programs.

Granted, the AISI is a relatively weak organization from an enforcement perspective. Its standards are voluntary. But think tanks and industry coalitions — as well as tech giants like Microsoft, Google, Amazon, and IBM, all of which signed the aforementioned letter — see the AISI as the most promising avenue to AI benchmarks that can form the basis of future policy.

There’s also concern among some interest groups that allowing the AISI to fold would risk ceding AI leadership to foreign nations. During an AI summit in Seoul in May 2024, international leaders agreed to form a network of AI Safety Institutes comprising agencies from Japan, France, Germany, Italy, Singapore, South Korea, Australia, Canada, and the European Union in addition to the U.K. and U.S.

“As other governments quickly move ahead, members of Congress can ensure that the U.S. does not get left behind in the global AI race by permanently authorizing the AI Safety Institute and providing certainty for its critical role in advancing U.S. AI innovation and adoption,” Jason Oxman, president and CEO of the Information Technology Industry Council, an IT industry trade association, said in a statement. “We urge Congress to heed today’s call to action from industry, civil society, and academia to pass necessary bipartisan legislation before the end of the year.”

TechCrunch has an AI-focused newsletter! Sign up here to get it in your inbox every Wednesday.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

These alternatives to popular apps can help reclaim your online life from billionaires and surveillance

There is immense power in being in control of your own data. As ownership and governance of...

The curious case of Nebius, the publicly traded AI infrastructure ‘startup’

On October 21, a new ticker opened to Nasdaq traders: NBIS, a truncation of Nebius, a fledgling...

How a digital “you” can sit through your agonizing web conference calls

Now you can appear to be on a Zoom call in your office, even when you’re sipping...

‘Wolfs’ sequel canceled because director ‘no longer trusted’ Apple

It may be hard to remember, but George Clooney and Brad Pitt co-starred in a movie, “Wolfs,”...

DOJ tells Google to sell Chrome

Welcome back to Week in Review. This week, we’re exploring the DOJ telling Google to sell off...

Tesla says it has reached a ‘conditional’ settlement in Rivian trade secrets lawsuit

Tesla and Rivian may have resolved a lawsuit in which Tesla accused Rivian of poaching employees and...

The rise and fall of the ‘Scattered Spider’ hackers

After evading capture for more than two years following a hacking spree that targeted some of the...

Trump’s tariff threats don’t scare this Mexican fintech

Mexico’s economic development — turbocharged by the amount of nearshoring in recent years — has made it...